Guggenheim Raises PT After Actavis (ACT) Has 1Q15 EPS Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Go back to Guggenheim Raises PT After Actavis (ACT) Has 1Q15 EPS Beat
May 11, 2015 6:32 AM EDT
Actavis (NYSE: ACT) reported Q1 EPS of $4.30, $0.38 better than the analyst estimate of $3.92. Revenue for the quarter came in at $4.23 billion versus the consensus estimate of $4.04 billion.
"Actavis achieved exceptional operational performance while simultaneously focusing on the completion of the Allergan acquisition and accelerating the integration of our combined company to create a Growth Pharma leader," said Brent... More
May 8, 2015 2:04 PM EDT
The Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
AES Corp. (NYSE: AES) - consensus EPS $0.25
Actavis (NYSE: ACT) - consensus EPS $3.94
Antares Pharma (Nasdaq: ATRS) - consensus loss $0.05
Centerpoint Energy (NYSE: CNP) - consensus EPS $0.33
Chimerix (Nasdaq: CMRX) - consensus loss $0.57
China XD Plastics (Nasdaq: CXDC) - no... More
